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Abstract  
One step melanoma surgery is, in fact, an innovative combined method for diagnosis and treatment of cutaneous 
melanoma (at the same time). The methodology allows an accurate assessment of the actual status of the 
affected patients by 1) clinical status, dermatoscopy, high-frequent ultrasonography (HFUS) of the pigmented 
lesion (eventually in combination with normal lymph nodes ultrasonography), followed by a single surgical 
intervention. Within this intervention, the primary tumour is removed with the appropriate surgical field, with or 
without parallel detection and draining lymph node biopsy (depending on the established tumour thickness). 
Removal of the lymph node may, in turn, be associated with or without locoregional lymphadenectomy, which is 
determined by its macroscopic appearance, established intraoperatively or after the histopathological evaluation. 
The methodology is sparing, innovative, easy to apply, tested in its functionality and logically justified. For an 
unknown reason, this methodology is not applicable in melanoma treatment’s guidelines in Europe and America. 
In Bulgaria and France, however, there are centres and hospitals that apply the technique mentioned above with 
enormous results, in particular in Bulgaria, the methodology is getting more and more improved to the current 
moment. Based on the above, as well as on the scant experience, we may share the opinion that the current 
melanoma treatment’s guidelines need major corrections in their recommendations, which are not optimal for 
patients due to the following facts: (1) the adverse effects on patients as a result of the necessity of at least 2 
surgical interventions; (2) the frequent occurrence of changes in the lymph flow after the primary excision; (3) the 
frequent non-obtaining of the suggested in the guidelines terms for re-excisions with or without sentinel lymph 
node removal; and (4) the creation of additional financial difficulties for the patients in the framework of two 
unneeded hospitalizations. 
 
 
 
 
Introduction 
 
One step melanoma surgery is not implicated 
as an idea yet, and not even as a possible opportunity 
for an eventual recent realisation or as a postulate in 
the recommendations of the American / European 
guidelines for melanoma’s treatment [1]. A little more 
encouraging is probably the situation with the 
European guideline for the diagnosis and treatment of 
melanoma, even though this approach is not even 
mentioned as an opportunity. This should be 
interpreted at least as critical. 
This "hot topic", however, has been already 
mentioned in some current publications in the world’s 
literature, but remains without an adequate or logical 
answer at the moment, unfortunately [1]? A solution of 
problems within a one-step model (a model with some 
advantages or advantages regarding at least the 
patients) appears to be considerably better as an 
option for clinical behaviour, especially if this model is 
compared to the actual one. The multistep model finds 
"the silent disapproval of the audience", but only few 
dare to rise against it loudly. In our previous 
manuscript, we tried to give a precise and accurate 
explanation of the problematic or "hot spots" (in the 
AJCC’s recommendations), which is “widely accepted” 
for unknown reasons, and they should not be even 
debated [1]? Or at least not in public debate [1]. 
 Tchernev. One Step Surgery for Cutaneous Melanoma 
_____________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2017 Oct 15; 5(6):774-776.                                                                                                                                                         775 
 
Interestingly, the ultrasound measurement of 
tumour thickness is also not incorporated (in AJCC’s / 
European recommendations for the treatment of 
melanoma as a way of facilitating the diagnostic 
approach, and hence a kind of opportunity for a more 
gentle clinical behaviour towards the patients 
themselves (regarding the number of surgical 
interventions). Namely this approach of a kind of 
"wrong" or "unconscionable" for patients as well as the 
health system of clinical behaviour, should be at least 
sharply criticised due to the following two points: 
1) the adverse effects on the patients 
themselves due to the necessity of at least two 
surgical interventions, as well as; 
 2) the creation of additional financial 
difficulties within the two hospitalisations. 
Thus, (in the current model of clinical behavior 
in patients with melanoma), prerequisites for 
increasing the number of visits to the clinician as well 
as the number of hospitalization are created indirectly 
(maybe also regarding the number of postoperative 
complications), and last but not least to create 
conditions for unnecessary high pays by the cashier to 
the appropriate treatment facilities as a second 
surgical intervention, for example. Or, in other words, 
isn’t it a matter of forming a kind of cartel (highlight a 
question)? 
“The cartel by definition is a form of monopoly 
unification or consent to maintain market shares of 
independent producers and to determine the quantity 
and price of the production offered in the industry. The 
cartel is one of the most serious violations of the rules 
of effective market competition. Its primary objective is 
to raise prices by reducing or eliminating the 
competition, which directly damages the consumers of 
goods and services. Cartels also harm the economy 
as a whole by removing of the enterprises’ stimuli for 
innovations and optimisations of their productivity." 
If you changed any of the terms in the above-
mentioned text, namely: "market shares" - with 
"medical services", "independent producers" -with 
"independent clinics", "offered production"- with 
“offered medical services", "damage to the 
consumers"- with "damage or disadvantages of the 
patients’ health" or with "prerequisites for damage of 
the patients’ health, ... or "strange complications?" 
Would that sound different? But at least, would that be 
somewhat logically justified or largely overlapping with 
the definition of a cartel? Parallels and equivalents 
should be sought precisely because optimization and 
perfection could be achieved only in this way. No 
matter if we talk about medicine or other activity. This 
erases the errors, and the corresponding system 
becomes more efficient. The lack of response from 
AJCC (as well as from the European guidelines for 
melanoma’s treatment) to these pressing issues at the 
moment makes we think in two directions: 
1) silence as the main sign of consent (with 
shared by us information); or 
2) there is a real lack useful move and 
explanation - so it would be better to be silent 
(whatever we say - we will still be wrong, and a useful 
move will not be found). 
Luckily or not, some clinics in Europe (in 
particular France and Bulgaria, and possibly other 
countries) increasingly ignore the AJCC’s criteria, 
even the European Melanoma’s Treatment Criteria. 
This, in turn, or at the expense of this, optimizes the 
clinical approach in certain patients’ groups. And it 
also creates some advantages for them. It should not 
be forgotten that the guidelines are not obligatory, but 
only recommended (by presumption and by definition) 
[1]. Isn’t it possible then these guidelines not to be 
strictly followed? Namely - by explaining their minuses 
(which are more than the pluses)? Within detailed 
discussions, even the patients are wondering how 
these guidelines support them or should we stick to 
them strictly? Informed consent of these patients for a 
certain divergent surgical intervention would be the 
best solution for the patient. And it works definitely! 
One of the main arguments that should be 
highlighted and confirming the suggestion shared by 
us is that the measured ultrasound tumour thickness 
(with high sensitive ultrasounds HFUS) correlated in a 
very high percentage of cases with the established 
postoperative histopathological thickness of Breslow. 
A fact, which is confirmed in some studies recently [2-
15]! 
We should ask ourselves - what then stops 
the innovations and who does not know that the 
proposed changes for a new melanoma’s clinical 
management guideline are beneficial? Furthermore, 
most of these benefits are directed only to the 
patients? Or that is precisely what prevents the 
progress and implication of these recommendations, 
... maybe? 
The European criteria for surgical treatment of 
melanoma from 2016 differ somewhat from those of 
the American Dermatologic Society (AJCC) as they 
are definitely more strict and clear to the surgeons, 
regarding the recommended surgical field: 5 mm for 
melanoma in situ, 1 cm for melanoma under 2 cm and 
2 cm for melanomas over 2 mm. Unfortunately, they 
also do not answer the urgent questions about the 
performance of high sensitivity ultrasound 
examination before the surgery. 
Despite this, isn’t it necessary these criteria 
be transformed and to introduce a new, uniform 
approach to the diagnosis and treatment of cutaneous 
melanoma? Cheaper and more reliable? Through 
simplification and logic to optimisation and progress? 
Or some colleagues need too much this second 
hospitalization and excision with draining lymph node 
removal, amounting to about 12 000 dollars (based on 
nonofficial data, personal conversations, unclear with 
or without sentinel lymph node removal or partial or 
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complete lymphadenectomy)? Or as they say: ʺIt’s 
nothing personal, it’s just business!ʺ 
Especially when it comes to patients requiring 
detection and removal of the corresponding draining 
lymph node: ...wouldn’t be this the best option to 
maintain an intact and authentic draining lymph flow? 
Wouldn’t this facilitate the approach in melanoma 
patient in general? The high-frequent ultrasonography 
in these cases would be a superb solution? As well as 
an unobstructed transition to one step melanoma 
surgery! 
Naturally, the risks of wrongly measured 
(lesser or greater) tumour thickness should not be 
ignored. These are errors that should be "swallowed" 
in the first place, because: (1) when a larger tumour 
thickness is established with simultaneous removal of 
the sentinel lymph node within one operative session; 
(2)… the patient does not lose anything in practice? 
An additional operation is not necessary, but a kind of 
"over-security" is provided at the same time? And if 
the tumour thickness is wrongly established (smaller 
than the real one), a re-excision has to be done with 
or without draining lymph node (depending on the 
already established tumour thickness).  
It is precisely the balance between these 
statements, criticisms; innovations, suggestions or ... 
whatever we call them .... has not been reached at the 
current moment. The quicker solution, or at least 
consensus achieving or balance on these key issues, 
I would even call them "destiny’s questions", for 
someone, would lead to more adequate and effective 
treatment of patients with melanoma. 
Solutions are often in front of us, and they just 
have to be accepted!  
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